Research progress on autologous blood patch pleurodesis
- VernacularTitle:自体血补片胸膜固定术的研究进展
- Author:
Jiawei HUANG
1
,
2
;
Hanping LIANG
1
,
2
;
Xihao XIE
1
,
2
;
Wanli LIN
1
,
2
Author Information
1. Department of Thoracic Surgery, Gaozhou People&rsquo
2. s Hospital, Maoming, 525200, Guangdong, P. R. China
- Publication Type:Journal Article
- Keywords:
Autologous blood patch pleurodesis;
persistent air leak;
pneumothorax;
review
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2025;32(01):136-140
- CountryChina
- Language:Chinese
-
Abstract:
Autologous blood patch pleurodesis (ABPP) was first proposed in 1987. Now it is mainly used to treat intractable pneumothorax and persistent air leakage after pneumonectomy, and also used to treat pneumothorax in children and other rare secondary pneumothorax. Persistent air leakage and pneumothorax of various causes are essentially alveolar pleural fistula. It can usually be treated by closed thoracic drainage, continuous negative pressure suction and surgery. Pleurodesis is a safe and effective alternative to surgery for patients who have failed conventional conservative treatment and can not receive operations. Compared with other pleurodesis adhesives, autologous blood (ABPP) is safer and more effective, and it is simple, painless, cheap and easy to be accepted by patients. But in the domestic and foreign researches in recent years, many details of ABPP treatment have not been standardized. For further research and popularization of ABPP, this article reviews the detailed regulations, efficacy and safety of this technology.
